Want to join the conversation?
$RF 2Q15 PR: Total revenues were $1,410MM vs. $1,279MM in 2Q14. Net income available to common shareholders of $269MM vs. $288MM in 2Q14. Diluted earnings per share were $0.20 vs. $0.21 in 2Q14. Net interest income was $820MM vs. $823MM in 2Q14. Net interest margin was 3.16% vs. 3.24% in 2Q14. Effective tax rate was 30.1%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)